Srdjan Stankovic
No más puestos en curso
Perfil
El Dr. Srdjan R. Stankovic, MD, es Presidente de ACADIA Pharmaceuticals, Inc. Forma parte del Consejo de Administración de Neurogene, Inc. Anteriormente, el Dr. Stankovic trabajó como Vicepresidente Senior de Desarrollo Clínico y Asuntos Médicos en Alkermes Plc, Vicepresidente Senior y Jefe de Desarrollo Clínico Global en Teva Pharmaceuticals USA, Inc, Vicepresidente de Asuntos Médicos y Desarrollo Clínico en Forest Laboratories, Inc, Director de Desarrollo y Vicepresidente Ejecutivo en Neurogen Corp, Vicepresidente Senior de Investigación Clínica Mundial en Cephalon, Inc, Vicepresidente de Desarrollo Clínico en Estados Unidos en Johnson & Johnson Pharmaceutical Research & Development LLC, y Vicepresidente de Desarrollo Clínico en Estados Unidos en UCB Pharma, Inc. Se licenció en la Universidad de Alabama y se doctoró en la Universidad de Belgrado.
Antiguos cargos conocidos de Srdjan Stankovic.
| Empresas | Cargo | Fin |
|---|---|---|
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Director/Board Member | 29/12/2023 |
| ACADIA PHARMACEUTICALS INC. | President | 31/12/2022 |
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 01/11/2015 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Corporate Officer/Principal | 01/01/2013 |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | 01/06/2010 |
Formación de Srdjan Stankovic.
| The University of Alabama | Graduate Degree |
| University of Belgrade | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Empresas privadas | 7 |
|---|---|
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | Health Technology |
Johnson & Johnson Pharmaceutical Research & Development LLC
 Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Johnson & Johnson Pharmaceutical Research & Development LLC provides research and development support services. It offers drug discovery and drug development in a variety of therapeutic areas, including CNS, Internal Medicine and Oncology, to address unmet medical needs worldwide. The company is headquartered in Raritan, NJ. | Commercial Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
UCB Pharma, Inc.
 UCB Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services UCB Pharma, Inc. provides research, development & commercialisation of pharmeceutical and biotechnology products. Its products are Keppra, Xyzal, Atarax, Lortab, Dipentum, and Tussionex. UCB Pharma develops small and large molecule treatments for a variety of diseases and ailemts. The company was founded by Emmanuel Janssen in 1928 and is headquartered in Smyrna, GA. | Commercial Services |
Neurogene, Inc.
Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Srdjan Stankovic
